Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
car-t cells targeting muci | mucin-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1/2 | unknown |
car-t cells targeting muci | mucin-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] T-Lymphocyte[MeSHID:D013601] Malignant neoplasm of lung[MeSHID:D008175] Glioblastoma[MeSHID:D005909] |
NA | phase 1 | unknown |
car-t cells targeting muci | mucin-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] T-Lymphocyte[MeSHID:D013601] Malignant neoplasm of lung[MeSHID:D008175] Glioblastoma[MeSHID:D005909] |
NA | phase 1/2 | unknown |
car-t cells targeting muci | mucin-1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] Pancreatic carcinoma[MeSHID:C562463] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1 | unknown |
click here to return to the previous page |